feed,title,long_url,short_url
Benzinga,Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis,https://benzinga.com/general/biotech/22/02/25533754/sanofi-regenerons-dupixent-under-fda-priority-review-for-children-under-5-years-with-atopic-derma,https://bit.ly/3GA9KcA
Benzinga,Cigarette Maker Philip Morris Beats On Q4 Earnings; Provides Positive FY22 Forecast,https://benzinga.com/news/earnings/22/02/25534159/cigarette-maker-philip-morris-beats-on-q4-earnings-provides-positive-fy22-forecast,https://bit.ly/3GEZLTu
